These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19020508)

  • 21. 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
    Tsai IJ; Croft KD; Mori TA; Falck JR; Beilin LJ; Puddey IB; Barden AE
    Free Radic Biol Med; 2009 Jan; 46(2):263-70. PubMed ID: 19013235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and insulin resistance in young people.
    Valente AM; Strong W; Sinaiko AR
    Am Heart J; 2001 Sep; 142(3):440-4. PubMed ID: 11526356
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glycemic index--relevant in the treatment of overweight and diabetes].
    Terry J; Terry P
    Lakartidningen; 2006 Feb 15-21; 103(7):466-70; discussion 471-3. PubMed ID: 16535876
    [No Abstract]   [Full Text] [Related]  

  • 25. Obesity and cardiovascular disease.
    Shaper AG
    Ciba Found Symp; 1996; 201():90-103; discussion 103-7, 188-93. PubMed ID: 9017276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea.
    Park HS; Yun YS; Park JY; Kim YS; Choi JM
    Asia Pac J Clin Nutr; 2003; 12(4):411-8. PubMed ID: 14672864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The obstructive sleep apnoea syndrome in obesity: a conspirator in the shadow].
    Salvador J; Iriarte J; Silva C; Gómez Ambrosi J; Díez Caballero A; Frühbeck G
    Rev Med Univ Navarra; 2004; 48(2):55-62. PubMed ID: 15382614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
    Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAI-1, obesity, insulin resistance and risk of cardiovascular events.
    Juhan-Vague I; Alessi MC
    Thromb Haemost; 1997 Jul; 78(1):656-60. PubMed ID: 9198234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and oxidative stress: a direct link to CVD?
    Higdon JV; Frei B
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):365-7. PubMed ID: 12639823
    [No Abstract]   [Full Text] [Related]  

  • 33. Bibliography. Current world literature. Clinical trials.
    Curr Opin Cardiol; 2008 Jul; 23(4):407-21. PubMed ID: 18520727
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders.
    Svendsen M; Blomhoff R; Holme I; Tonstad S
    Eur J Clin Nutr; 2007 Nov; 61(11):1301-11. PubMed ID: 17268408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risks in firefighters: implications for occupational health nurse practice.
    Byczek L; Walton SM; Conrad KM; Reichelt PA; Samo DG
    AAOHN J; 2004 Feb; 52(2):66-76. PubMed ID: 14979617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors.
    Claessens M; van Baak MA; Monsheimer S; Saris WH
    Int J Obes (Lond); 2009 Mar; 33(3):296-304. PubMed ID: 19153580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction.
    Krzystek-Korpacka M; Patryn E; Boehm D; Berdowska I; Zielinski B; Noczynska A
    Clin Biochem; 2008 Aug; 41(12):943-9. PubMed ID: 18501708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):581-601, vii-viii. PubMed ID: 18775353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.